BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19788873)

  • 41. Cancer modeling and network biology: accelerating toward personalized medicine.
    Masoudi-Nejad A; Wang E
    Semin Cancer Biol; 2015 Feb; 30():1-3. PubMed ID: 24969134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A piece in the puzzle of personalized medicine.
    Kroemer HK; Meyer zu Schwabedissen HE
    Clin Pharmacol Ther; 2010 Jan; 87(1):19-20. PubMed ID: 20019696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decision science and cervical cancer.
    Cantor SB; Fahs MC; Mandelblatt JS; Myers ER; Sanders GD
    Cancer; 2003 Nov; 98(9 Suppl):2003-8. PubMed ID: 14603536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
    Rizzo JD
    Best Pract Res Clin Haematol; 2005; 18(3):439-48. PubMed ID: 15792918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pathology- a new revival].
    Barshack I
    Harefuah; 2013 Jun; 152(6):315-6, 370. PubMed ID: 23885459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase.
    Groenen PJ; Blokx WA; Diepenbroek C; Burgers L; Visinoni F; Wesseling P; van Krieken JH
    Histopathology; 2011 Jul; 59(1):1-7. PubMed ID: 21477258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of biomarkers in multiple sclerosis.
    Bielekova B; Martin R
    Brain; 2004 Jul; 127(Pt 7):1463-78. PubMed ID: 15180926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ligand-based targeted therapy for cancer tissue.
    Das M; Mohanty C; Sahoo SK
    Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Anatomical pathology and molecular diagnosis].
    Paltsev MA; Severin ES; Ivanov AA
    Arkh Patol; 2006; 68(4):3-7. PubMed ID: 16986485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
    J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of consequential reasoning in cancer chemotherapy.
    Hudson DL; Cohen ME; Hudson SE
    Stud Health Technol Inform; 2001; 84(Pt 2):1349-53. PubMed ID: 11604947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biobanking: the foundation of personalized medicine.
    Hewitt RE
    Curr Opin Oncol; 2011 Jan; 23(1):112-9. PubMed ID: 21076300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How the science of personalized medicines will change the clinical management of patients in the pharmacy.
    Airley R; Evans A
    Future Med Chem; 2012 Oct; 4(16):2023-7. PubMed ID: 23157235
    [No Abstract]   [Full Text] [Related]  

  • 56. Upcoming battles in the war on cancer.
    Rose S
    Cancer Discov; 2011 Dec; 1(7):544-6. PubMed ID: 22586673
    [No Abstract]   [Full Text] [Related]  

  • 57. Personalised treatment of haematological malignancies through systems medicine based on single molecules in single cells.
    Karimiani EG; Day P
    Integr Biol (Camb); 2013 May; 5(5):759-67. PubMed ID: 23532213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management?
    Roukos DH
    Expert Rev Mol Diagn; 2010 Apr; 10(3):247-50. PubMed ID: 20370580
    [No Abstract]   [Full Text] [Related]  

  • 59. Systems oncology: towards patient-specific treatment regimes informed by multiscale mathematical modelling.
    Powathil GG; Swat M; Chaplain MA
    Semin Cancer Biol; 2015 Feb; 30():13-20. PubMed ID: 24607841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination - an effective strategy to improve clinical treatment.
    Lu DY; Chen XL; Ding J
    Med Hypotheses; 2006; 66(1):45-51. PubMed ID: 16168568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.